✦ LIBER ✦

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors

✍ Scribed by Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Icrucumab, a fully human monoclonal anti

✍ Patricia M. LoRusso, Smitha Krishnamurthi, Hagop Youssoufian, Nancy Hall, Floyd 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 176 KB

1247 Phase I study of nimotuzumab, a hum

✍ N. Boku; K. Yamazaki; A. Fukutomi; T. Takahashi; N. Yamamoto; M. Miyazaki; T. Sa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

648 POSTER A phase I dose-escalation stu

✍ C. Higano; M. Gordon; P. LoRusso; F. Fox; T. Katz; J. Roecker; E. Rowinsky; H. Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

554 POSTER Pharmacokinetic (PK) and phar

✍ M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Safety, Tolerability, Pharmacokinetics a

✍ Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 157 KB

208 HGS-ETR1, a fully human monoclonal a

✍ S.J. Hotte; A.M. Oza; L.H. Le; M. MacLean; A. Iacobucci; A. Corey; N.L. Fox; H.W 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB